Active immunization (cancer vaccine) and ex vivo proliferation of antigen-specific T cells followed by adoptive cell transfer (ACT) are promising approaches to potentiate anti-TC T cells using the candidate antigens as mentioned above (e.g., TG and CEA). The gene discussed is CEACAM5; the disease is cancer.